Targeting TGF-β for treatment of osteogenesis imperfecta.
J Clin Invest. 2022 Apr 1;132(7):e152571. doi: 10.1172/JCI152571.
J Clin Invest. 2022.
PMID: 35113812
Free PMC article.
Clinical Trial.